Apimeds Pharmaceuticals US (APUS) Long-Term Debt Repayments (2025)
Apimeds Pharmaceuticals US (APUS) reported Long-Term Debt Repayments of $250,000 for Q4 2025.
Powered by 
Analysis
Apimeds Pharmaceuticals US (APUS) Long-Term Debt Repayments (2025) Analysis & Trends
For FY2025, Apimeds Pharmaceuticals US posted Long-Term Debt Repayments of $343,800.
- By year, Long-Term Debt Repayments came in at $31,900 in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,154.60 Bn | 1,123.18 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 624.15 Bn | 542.68 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 512.14 Bn | 485.26 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 365.44 Bn | 319.81 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 297.27 Bn | 261.26 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 261.41 Bn | 235.09 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 234.57 Bn | 189.96 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 192.90 Bn | 167.10 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn | - |
| 10 | Apimeds Pharmaceuticals US | 5.65 Mn | -13.98 Mn | - | - |
API Access
Apimeds Pharmaceuticals US Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=APUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "APUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=APUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();